CSPC PHARMACEUTGR Valuation
| CVGU Stock | EUR 2.18 0.10 4.81% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. CSPC PHARMACEUTGR ADR4 shows a prevailing Real Value of €1.83 per share. The current price of the firm is €2.18. Our model approximates the value of CSPC PHARMACEUTGR ADR4 from analyzing the firm fundamentals such as shares outstanding of 2.98 B, and Profit Margin of 0.19 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CSPC PHARMACEUTGR's price fluctuation is dangerous at this time. Calculation of the real value of CSPC PHARMACEUTGR ADR4 is based on 3 months time horizon. Increasing CSPC PHARMACEUTGR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CSPC stock is determined by what a typical buyer is willing to pay for full or partial control of CSPC PHARMACEUTGR ADR4. Since CSPC PHARMACEUTGR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CSPC Stock. However, CSPC PHARMACEUTGR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.18 | Real 1.83 | Hype 2.18 | Naive 2.05 |
The real value of CSPC Stock, also known as its intrinsic value, is the underlying worth of CSPC PHARMACEUTGR ADR4 Company, which is reflected in its stock price. It is based on CSPC PHARMACEUTGR's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CSPC PHARMACEUTGR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CSPC PHARMACEUTGR ADR4 helps investors to forecast how CSPC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CSPC PHARMACEUTGR more accurately as focusing exclusively on CSPC PHARMACEUTGR's fundamentals will not take into account other important factors: CSPC PHARMACEUTGR Total Value Analysis
CSPC PHARMACEUTGR ADR4 is currently forecasted to have takeover price of 0 with market capitalization of 12.8 B, debt of 316.71 M, and cash on hands of 9.28 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CSPC PHARMACEUTGR fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 12.8 B | 316.71 M | 9.28 B |
CSPC PHARMACEUTGR Investor Information
The company last dividend was issued on the 8th of September 2022. Based on the analysis of CSPC PHARMACEUTGR's profitability, liquidity, and operating efficiency, CSPC PHARMACEUTGR ADR4 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in May.CSPC PHARMACEUTGR Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of CSPC implies not a very effective usage of assets in April.CSPC PHARMACEUTGR Profitability Analysis
The company reported the revenue of 30.72 B. Net Income was 5.47 B with profit before overhead, payroll, taxes, and interest of 21.14 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CSPC PHARMACEUTGR's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CSPC PHARMACEUTGR and how it compares across the competition.
About CSPC PHARMACEUTGR Valuation
The stock valuation mechanism determines CSPC PHARMACEUTGR's current worth on a weekly basis. Our valuation model uses a comparative analysis of CSPC PHARMACEUTGR. We calculate exposure to CSPC PHARMACEUTGR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CSPC PHARMACEUTGR's related companies.CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. CSPC PHARMACEUT operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21527 people.
8 Steps to conduct CSPC PHARMACEUTGR's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CSPC PHARMACEUTGR's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CSPC PHARMACEUTGR's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CSPC PHARMACEUTGR's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CSPC PHARMACEUTGR's revenue streams: Identify CSPC PHARMACEUTGR's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CSPC PHARMACEUTGR's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CSPC PHARMACEUTGR's growth potential: Evaluate CSPC PHARMACEUTGR's management, business model, and growth potential.
- Determine CSPC PHARMACEUTGR's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CSPC PHARMACEUTGR's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CSPC Stock analysis
When running CSPC PHARMACEUTGR's price analysis, check to measure CSPC PHARMACEUTGR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC PHARMACEUTGR is operating at the current time. Most of CSPC PHARMACEUTGR's value examination focuses on studying past and present price action to predict the probability of CSPC PHARMACEUTGR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC PHARMACEUTGR's price. Additionally, you may evaluate how the addition of CSPC PHARMACEUTGR to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |